INLIF LIMITED - Class A Ordinary shares (INLF)

Quanzhou, China, Oct. 19, 2026 (GLOBE NEWSWIRE) -- INLIF LIMITED (Nasdaq: INLF) (together with all its subsidiaries and consolidated entities, the "Company" or "INLIF"), a company engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms, today announced that it has entered into securities purchase agreements with certain institutional investors for the purchase and sale of an aggregate of 435,000 Class A Ordinary Shares, par value of US$0.0001 per share, of the Company (the “Ordinary Shares”), pre-funded warrants to purchase up to 1,908,750 Ordinary Shares (the “Pre-Funded Warrants”), Series A warrants to initially purchase up to 2,343,750 Ordinary Shares (the “Series A Warrants”), Series B warrants to initially purchase up to 2,343,750 units (the “Series B Warrants”, each unit consisting of one Ordinary Share, or one Pre-Funded Warrant in lieu thereof and one Series A Warrant ), and Series C warrants to purchase a number of Ordinary Shares to be determined in accordance with their terms (the “Series C Warrants” and, together with the Series A Warrants and the Series B Warrants, the “Ordinary Warrants”), in a registered direct offering (the “Offering”). Each Ordinary Share or Pre-Funded Warrant will be sold together with one accompanying Series A Warrant, one accompanying Series B Warrant and one accompanying Series C Warrant at a combined purchase price of US$1.60 per Ordinary Share and accompanying Ordinary Warrants, or US$1.5999 per Pre-Funded Warrant and accompanying Ordinary Warrants, which equals the combined purchase price per Ordinary Share and accompanying Ordinary Warrants minus US$0.0001, the exercise price of each Pre-Funded Warrant. The aggregate gross proceeds from the Offering are expected to be approximately US$3.75 million, prior to deducting placement agent fees, legal fees, administrative and other offering-related expenses.

As investors continue searching for emerging growth opportunities, several technology, biotechnology, healthcare, industrial automation, and digital infrastructure companies trading under $2 are attracting attention following recent corporate developments spanning Artificial Intelligence (AI), AI Infrastructure, Robotics, Healthcare Technology, Graphene, and Advanced Manufacturing.

As investors continue searching for undiscovered opportunities beyond the large-cap market, a new wave of nanocap companies is attracting attention across some of today's fastest-growing sectors, including critical minerals, industrial automation, fusion energy, renewable hydrogen, biotechnology, and advanced manufacturing. While nanocap investing carries higher risk, these emerging companies are positioning themselves in industries that could experience significant long-term expansion.